Conclusions and Future Perspectives The collective evidence positions incretin receptor agonists as a unique class of drugs with multi-organ anti-fibrotic potential, now extending to fibro-inflammatory diseases like osteoarthritis
Monitor blood sugar levels regularly
[PubMed: 37343084] 161
Why people choose it: Dual-action mechanism for superior appetite and metabolic control Highest weight loss percentages of any approved medication Reduces emotional and mindless eating patterns Improves multiple metabolic risk factors simultaneously Once-weekly injection Common side effects: Similar to semaglutide nausea, diarrhea, constipation, and decreased appetite
In suboptimal health individuals characterized by stress-induced fatigue, subclinical inflammation, or impaired elasticity, the adaptive properties of SC offer specific benefits, helping the body resist stress and maintain homeostasis
Traditionally, injectable therapies have faced resistance from some patients due to needle anxiety and inconvenience
